87/100BParker-Hannifin stock forecast 2027–2031
Analysts' average 12-month price target for Parker-Hannifin is 1,140.67, 24.4% above the current price of 917.22. Their targets range from 950.00 to 1,358.00.
Of the 19 firms that rated Parker-Hannifin in the past 12 months, 16 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 950.00 to 1,358.00, with an average of 1,140.67.
| Strong buy | 0 | |
| Buy | 16 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 1,358.00 |
| Average target | 1,140.67 |
| Lowest target | 950.00 |
| Current price | 917.22 |
Parker-Hannifin price target history
Have analysts recently raised or lowered their Parker-Hannifin price target and rating?
How analysts rate Parker-Hannifin, month by month
16 of 19 firms rate it buy now, against 14 of 18 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Parker-Hannifin analyst upgrades, downgrades and price targets
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 19 Oct 2026 | Stifel Nicolaus | — | 1,075.00 → 1,002.00 | -6.8% | 963.34 |
| 15 Oct 2026 | Mizuho Securities | — | 1,050.00 → 1,200.00 | +14.3% | 956.32 |
| 14 Oct 2026 | UBS | — | 1,250.00 → 950.00 | -24.0% | 960.60 |
| 24 Sept 2026 | Wells Fargo | — | 950.00 → 1,050.00 | +10.5% | 974.98 |
| 14 Aug 2026 | Bernstein Varun Govindaraj | Reiterated · Outperform | 1,037.00 → 1,218.00 | +17.5% | 1,057.28 |
| 7 Aug 2026 | Truist Financial | Reiterated · Buy | 1,269.00 → 1,358.00 | +7.0% | 1,079.69 |
| 7 Aug 2026 | Stifel Nicolaus Nathan Jones | — | 1,000.00 → 1,075.00 | +7.5% | 1,081.58 |
| 7 Aug 2026 | BMO Capital Daniel DiCicco | — | 1,090.00 → 1,214.00 | +11.4% | 1,069.80 |
| 7 Aug 2026 | UBS Amit Mehrotra | Reiterated · Buy | 1,250.00 | — | 1,069.80 |
| 7 Aug 2026 | KeyBanc | Reiterated · Overweight | 1,100.00 → 1,210.00 | +10.0% | 1,069.80 |
| 16 Jul 2026 | Bernstein Varun Govindaraj | — | 1,026.00 → 1,037.00 | +1.1% | 973.10 |
| 2 Jul 2026 | Truist Financial Jamie Cook | Reiterated · Buy | 1,147.00 → 1,269.00 | +10.6% | 963.81 |
| 9 Jun 2026 | Bernstein Varun Govindaraj | — | 1,026.00 | — | 905.53 |
| 26 May 2026 | Wells Fargo Joseph O'Dea | Reiterated · Overweight | 1,000.00 → 950.00 | -5.0% | 866.96 |
| 11 May 2026 | Evercore ISI | — | 1,064.00 | — | 870.10 |
| 1 May 2026 | Truist Financial | — | 1,139.00 → 1,147.00 | +0.7% | 889.27 |
| 1 May 2026 | Mizuho Securities Brett Linzey | — | 825.00 → 1,050.00 | +27.3% | 895.30 |
| 10 Apr 2026 | Stifel Nicolaus | Reiterated · Hold | 965.00 → 1,000.00 | +3.6% | 983.17 |
| 26 Mar 2026 | BMO Capital | — | 1,090.00 | — | 901.46 |
| 24 Feb 2026 | Morgan Stanley | Reiterated · Equal Weight | 945.00 → 1,038.00 | +9.8% | 1,018.77 |
| 30 Jan 2026 | Truist Financial | — | 1,097.00 → 1,139.00 | +3.8% | 936.20 |
| 30 Jan 2026 | KeyBanc | — | 1,050.00 → 1,100.00 | +4.8% | 948.40 |
| 30 Jan 2026 | Stifel Nicolaus | Reiterated · Hold | 941.00 → 965.00 | +2.6% | 948.40 |
| 30 Jan 2026 | Robert W. Baird | — | 1,050.00 | — | 948.40 |
| 30 Jan 2026 | Barclays | Reiterated · Overweight | 990.00 → 1,020.00 | +3.0% | 948.40 |
| 29 Jan 2026 | Industrial Alliance Securities | — | 1,032.00 | — | 948.40 |
| 23 Jan 2026 | Stifel Nicolaus | Reiterated · Hold | 869.00 → 941.00 | +8.3% | 932.70 |
| 14 Jan 2026 | Morgan Stanley Christopher Snyder | Reiterated · Equal Weight | 945.00 | — | 931.66 |
| 7 Jan 2026 | Barclays | Reiterated · Overweight | 950.00 → 990.00 | +4.2% | 928.76 |
| 7 Jan 2026 | Wells Fargo Joseph O'Dea | Reiterated · Overweight | 710.00 → 1,000.00 | +40.8% | 928.76 |
| 6 Jan 2026 | KeyBanc Jeffrey Hammond | Reiterated · Overweight | 935.00 → 1,050.00 | +12.3% | 906.89 |
| 18 Dec 2025 | Truist Financial | Reiterated · Buy | 977.00 → 1,097.00 | +12.3% | 874.17 |
| 16 Dec 2025 | Stifel Nicolaus | Reiterated · Hold | 723.00 → 869.00 | +20.2% | 871.56 |
| 16 Dec 2025 | Goldman Sachs | — | 1,000.00 | — | 883.45 |
| 4 Dec 2025 | Barclays Julian Mitchell | Reiterated · Overweight | 785.00 → 950.00 | +21.0% | 869.20 |
| 4 Dec 2025 | BNP Paribas | — | 1,020.00 | — | 869.20 |
| 12 Nov 2025 | Susquehanna Philip Walsh | Reiterated · Positive | 1,000.00 | — | 857.93 |
| 9 Nov 2025 | Truist Financial | — | 910.00 → 977.00 | +7.4% | 844.01 |
| 7 Nov 2025 | KeyBanc | Reiterated · Overweight | 825.00 → 935.00 | +13.3% | 839.75 |
Parker-Hannifin EPS and revenue estimates
Analysts expect Parker-Hannifin's EPS to grow 15.6% a year until 2029. Over the last 5 years it grew 16.4% a year, and over the last 3 years 21.1%.
Analysts expect Parker-Hannifin's revenue to grow 9.6% a year until 2029. Over the last 5 years it grew 8.4% a year, and over the last 3 years 4.1%.
Revenue
EPS
Does Parker-Hannifin beat earnings estimates?
On average, analysts' EPS estimate was 7.4% off the result, either way, and their revenue estimate 1.7%, over the last 12 quarters.
- EPS beats
- 110 / 136
- Revenue beats
- 96 / 120
- Average EPS surprise, last 12
- +7.4%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 5 Nov 2026 | 8.21 | 8.90 | +8.4% | 5.81B | 5.99B | +3.2% |
| Q4 FY2026 | 6 Aug 2026 | 8.31 | 9.27 | +11.6% | 5.57B | 5.76B | +3.3% |
| Q3 FY2026 | 30 Apr 2026 | 7.84 | 8.17 | +4.2% | 5.40B | 5.49B | +1.6% |
| Q2 FY2026 | 29 Jan 2026 | 7.16 | 7.65 | +6.8% | 5.07B | 5.17B | +2.0% |
| Q1 FY2026 | 6 Nov 2025 | 6.62 | 7.22 | +9.1% | 4.94B | 5.08B | +2.9% |
| Q4 FY2025 | 7 Aug 2025 | 7.10 | 7.69 | +8.3% | 5.12B | 5.24B | +2.5% |
| Q3 FY2025 | 1 May 2025 | 6.72 | 6.94 | +3.3% | 4.99B | 4.96B | -0.6% |
| Q2 FY2025 | 30 Jan 2025 | 6.23 | 6.53 | +4.8% | 4.81B | 4.74B | -1.5% |
| Q1 FY2025 | 31 Oct 2024 | 6.14 | 6.20 | +1.0% | 4.90B | 4.90B | +0.1% |
| Q4 FY2024 | 8 Aug 2024 | 6.22 | 6.77 | +8.8% | 5.08B | 5.19B | +2.1% |
| Q3 FY2024 | 2 May 2024 | 6.15 | 6.51 | +5.9% | 5.07B | 5.07B | +0.2% |
| Q2 FY2024 | 1 Feb 2024 | 5.26 | 6.15 | +16.9% | 4.82B | 4.82B | +0.1% |
Parker-Hannifin stock price 2027–2031: scenarios
If Parker-Hannifin's earnings keep growing at the 10.9% a year analysts expect to FY2029, it would earn about 54.15 a share in FY2031. At the P/E it has traded at over the last five years (22.6 to 33.9) that is 1,225.88 to 1,833.27 a share, or 1,407.16 at its average P/E of 26.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 35.73 | 808.96 | 928.59 | 1,209.78 |
| FY2028 | 39.92 | 903.84 | 1,037.50 | 1,351.67 |
| FY2029 | 44.04 | 997.12 | 1,144.58 | 1,491.18 |
| FY2030 (extrapolated) | 48.84 | 1,105.60 | 1,269.10 | 1,653.40 |
| FY2031 (extrapolated) | 54.15 | 1,225.88 | 1,407.16 | 1,833.27 |
Each year's EPS is the analysts' consensus to FY2029; the years after continue its 10.9% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (22.6, 26.0, 33.9).
Is Parker-Hannifin stock undervalued or overvalued?
Parker-Hannifin's P/E of 31.1 is above the middle of its 5-year range (18.0 to 39.1, median 27.4). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history. Buyers pay about the usual price for each point of growth: a PEG of 2.0 on expected growth against 1.7 on its median P/E and past five years' growth. At its usual P/E (27.5 × EPS of 29.52), Parker-Hannifin's fair value is 813.15; the price, 917.22, is 12.8% above it. Its forward P/E, on the consensus for FY2027, is 25.7.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (21.1 and 39.1). The price against its P/E range
- Price to earnings ratio (TTM)
- 31.07
- Five-year median P/E
- 27.37
- Five-year P/E range
- 18.0 – 39.1
- Forward P/E (FY2027)
- 25.67
- PEG ratio
- 2.86
- To the average target
- +24.4%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.10146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.